Abstract
Purpose: This study aimed to compare the effects of ticagrelor and clopidogrel on early neointimal healing assessed with optical coherence tomography (OCT) after drug-eluting stent (DES) implantation in patients with acute myocardial infarction (AMI). Materials and Methods: AMI patients were randomly assigned to either the ticagrelor or clopidogrel arm. After DES implantation, OCT was performed to assess the percentages of uncovered struts immediately after procedure and 3 months later. Results: Due to early termination, 83 patients out of 106 initially enrolled patients (24% of planned participants) underwent 3-month OCT. Differences in vascular healing patterns between the two groups, including percentage of uncovered struts on 3-month OCT (9.6% vs. 11.7% in ticagrelor vs. clopidogrel, respectively; p=0.867), neointimal thickness, percentage of malapposed struts, and healing scores did not reach statistical significance. The predictors of uncovered strut on 3-month OCT included greater reference vessel diameter [odds ratio (OR)=1.96, p<0.001] and more malapposed struts (OR=1.12, p=0.003). Conclusion: The current study did not explore favorable effect of ticagrelor on 3-month vascular healing after DES implantation. Our findings should only be considered for generating hypothesis, due to insufficient power.
Original language | English |
---|---|
Pages (from-to) | 624-632 |
Number of pages | 9 |
Journal | Yonsei medical journal |
Volume | 59 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2018 Jul |
Bibliographical note
Funding Information:This research was conducted with support from the Investigator Sponsored Study Program of AstraZeneca and Biotronik, and the Cardiovascular Research Center in Seoul, Korea.
Publisher Copyright:
© Yonsei University College of Medicine 2018.
All Science Journal Classification (ASJC) codes
- Medicine(all)